Texas Oncology

El Paso, Texas 79915

1 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Breast Cancer, Cancer, Cancer Metastatic, HER2 Positive Breast Cancer, Malignant Neoplasm, Malignant Solid Neoplasm, Malignant Solid Tumor, Malignant Tumor, Melanoma, Metastasis

Studies at this site

• Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63) — Recruiting now
• Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1) — Running, not enrolling
• Study in Patients With Unresectable And Metastatic Melanoma: The Optimize Study — Completed
• A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC) — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early